Table 1.
Radiotherapy dose in ASPS.
| Year | Author | Location | Dose | Effect |
| 2016 | Chen Z et al | Multiple brain metastases | Whole-brain radiotherapy with 30 Gy | Prognosis was poor |
| 2014 | Emmez H | Primary intracerebral ASPS | 54 Gy (RT+ chemotherapy after gross total excision) | PFS achieved 45 mo |
| 2014 | Mullins BT | Larynx | Total dose of 59.4 Gy | DFS for 4 mo |
| 2014 | Mullins BT | Parotid gland | Total dose of 63.4 Gy | DFS for 168 mo |
| 2014 | Meng N | Recurrent ASPS of the tongue | Iodine-125 | achieved CR +recurrent-free survival >30 mo |
| 2013 | Nakao K | The upper third of the vagina | carbon-ion RT with 67.2 Gy in 16 fractions | without recurrence for 20 mo |
| 2010 | Hanzer M | Single lung metastasis of ASPS | Hyperfractionated local RT with total dose of 44.8 Gy | |
| 2008 | Sidi et al | The left thigh | 50.4 Gy followed by a boost to the tumour area with 9 Gy (after chemotherapy + surgery) | Not well (bilateral pulmonary metastases immediately appeared) |